Fentanyl Quality Assurance Project Prompted Change in Clinical Workflow and Test Configurations.

ABSTRACT:

Background

Deaths attributable to fentanyl (FEN, a synthetic opioid) are high in Appalachia and highest in West Virginia. The goal of the study was to determine FEN prevalence among specimens submitted for definitive opioid testing and monitor responses to provider notifications of unexpected FEN findings during Q1 2020.

Methods

All definitive opioid test data were reviewed daily for FEN signatures in Q1 2020. Unexpected FEN results were communicated to providers and monitored for 10 days to record actions taken. Prevalence data were categorized. Behavioral Medicine (BMED) leaders analyzed January data and implemented FEN screening in the clinic. BMED Q1 clinic visits and order volumes for drug screens were reviewed after Q1.

Results

FEN positivity was 11% in Q1; >60%

SUBMITTER: Tacker DH 

PROVIDER: S-EPMC8415574 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature